Carcinoma, Renal Cell: all 1,992 studies
Page 3 of 20. Open to participants first (387), then studies with results posted, then the rest; newest registration first within each.
- Systemic Treatment Alone Versus Systemic Treatment Plus Radiotherapy in Oligometastatic Renal Cell CarcinomaRecruitingNCT06467097Phase 3
- An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney CancerRecruitingNCT06447103Phase 2
- A Study of VET3-TGI in Patients With Solid TumorsRecruitingNCT06444815Phase 1
- Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE TrialRecruitingNCT06432036Phase 1/2
- [18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT06428708Early Phase 1
- Oncological and Perioperative Outcomes of Laparoscopic Versus Robotic Partial Nephrectomy for Treatment of Renal Tumors.RecruitingNCT06424080Not applicable
- A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works in Adult Participants Who Have Cancer With Tumors That Have Spread in Their BodyRecruitingNCT06413680Phase 1/2
- CBM588 Capsules in Combination With Nivolumab and Ipilimumab for the Treatment of Advanced Stage Kidney CancerRecruitingNCT06399419Phase 1
- Establishment of a Multidimensional Prediction Model for the Natural Course of VHL Disease-related Renal Cell CarcinomaRecruitingNCT06391879
- Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell CarcinomaRecruitingNCT06376669Phase 2
- CARE1 Pragmatic Clinical TrialRecruitingNCT06364631Phase 3
- Plasma Metabolic Biomarkers for Multi-Cancer DiagnosisRecruitingNCT06363123
- A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab MonotherapyRecruitingNCT06362369Phase 1/2
- Immune Checkpoint Inhibitor Response in Solid Tumors Using a Live Tumor Diagnostic PlatformRecruitingNCT06349642
- The Optimal Number of Fiducial Marker for Stereotactic Body RadiotherapyRecruitingNCT06342323
- European Active Surveillance of Renal Cell Carcinoma Study (EASE RCC Study)RecruitingNCT06336187
- Study to Evaluate LB-LR1109, Administered Alone for the Treatment of Solid Tumor and in Combination With Atezolizumab for the Treatment of NSCLCRecruitingNCT06332755Phase 1
- Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial NephrectomyRecruitingNCT06322745Not applicable
- A Study of JMKX003948 Tablets in Patients With Renal Cell CarcinomaRecruitingNCT06321250Phase 1
- Fruquintinib Plus Everolimus as 2nd Line Therapy of ccRCC Patients Progressed Post IO and TKI TherapyRecruitingNCT06317298Not applicable
- Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary CarcinomaRecruitingNCT06302569Phase 2
- Comparison of Outcomes of Multiple Platforms for Assisted Robotic-Kidney (COMPAR-K)RecruitingNCT06290427Not applicable
- A Study of IBI363 in Subjects with Advanced Solid MalignanciesRecruitingNCT06281678Phase 2
- Upfront Immune Checkpoint Inhibitors With Deferred Cytoreductive Nephrectomy for Metastatic Renal Cell CarcinomaNot yet recruitingNCT06279403Phase 2
- A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid TumorsRecruitingNCT06270706Phase 1
- Comparison of In-Home Versus In-Clinic Administration of Subcutaneous Nivolumab Through Cancer CARE (Connected Access and Remote Expertise) Beyond Walls (CCBW) ProgramRecruitingNCT06265285Phase 2
- GM103 Intratumoral Injection in Patients With Locally Advanced, Unresectable, Refractory and/or Metastatic Solid TumorsRecruitingNCT06265025Phase 1/2
- A Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior ImmunotherapyRecruitingNCT06255223Phase 2
- A Study of MGC026 in Participants With Advanced Solid TumorsRecruitingNCT06242470Phase 1
- A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell CarcinomaRecruitingNCT06234605Phase 1
- Study to Evaluate the Safety and Efficacy of Bicalutamide in Combination With Sunitinib in Patients With TKIs-resistant RCCRecruitingNCT06222593Phase 1/2
- A Study of HB0025 Injection in Patients With Advanced Renal CancerRecruitingNCT06222125Phase 2
- Safety and Efficacy of TT-00420 Tablets Combined With Toripalimab Injection in Advanced Urological TumorsNot yet recruitingNCT06221774Phase 1/2
- Proteomic Guided First-line Precision Treatment of Renal Clear Cell CarcinomaRecruitingNCT06211790Phase 2
- Study to Evaluate the Efficacy and Safety of Immunotherapy With Axitinib in Advanced Collecting Duct CarcinomaRecruitingNCT06211114Phase 2
- Mechanisms of Somatic Mutation and Tumor Initiation in Pre-malignant Kidney Tubule CellsRecruitingNCT06194669
- CD70-targeted CAR-NKT Cells(CGC729) Therapy in the Renal Cell CarcinomaRecruitingNCT06182735Phase 1
- Head-to-head Comparison of Positron Nuclide Radio-labeled FAPI and 18F-FDG PET/CT in Patients With Malignant TumorsRecruitingNCT06182644Not applicable
- Kidney Cancer Observational ProtocolRecruitingNCT06147349
- Multi-classifier System for Stratifying Stage III Papillary Renal Cell Carcinoma of Receiving Adjuvant TherapyNot yet recruitingNCT06146777Phase 3
- KIDNEY-PAGER: Analysis of Circulating Tumor DNA as a Biomarker in Renal Cancer - an Observational TrialEnrolling by invitationNCT06145139
- Low Pressure Versus Standard Pressure Pneumoperitoneum in Laparoscopic NephrectomyNot yet recruitingNCT06134700Not applicable
- Pucotenlimab Combined With Lenvatinib as a Neodjuvant Therapy for Non Clear Cell Renal Cell CarcinomaNot yet recruitingNCT06129955Phase 2
- Locally Ablative TherapY in Oligo-ProgressiVe GEnitourinary TumoRs (LAYOVER)RecruitingNCT06101290Not applicable
- Delving Into Participation Trends in Renal Cell Carcinoma StudiesNot yet recruitingNCT06093568
- Contrast-enhanced CT-based Deep Learning Model for Preoperative Prediction of Disease-free Survival (DFS) in Localized Clear Cell Renal Cell Carcinoma (ccRCC)RecruitingNCT06088134
- PET/MR for Characterization of Renal Masses (RMs)RecruitingNCT06076538
- Phase 2 Study of Combination Tivozanib and Nivolumab in Advanced Non-Clear Cell Renal Cell CarcinomaRecruitingNCT06053658Phase 2
- A Study of HS-10516 in Patients With Advanced Clear Cell Renal Cell CarcinomaNot yet recruitingNCT06049030Phase 1
- Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain MetastasisRecruitingNCT06047379Phase 1/2
- Multimodal Recurrence Scoring System for Stratifying Stage III Clear Cell Renal Cell Carcinoma of Receiving Adjuvant TreatmentNot yet recruitingNCT06032728Not applicable
- KO-2806 Monotherapy and Combination Therapies in Advanced Solid TumorsRecruitingNCT06026410Phase 1
- A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT06010875Phase 1
- Molecular Residual Disease (MRD) Guided Adjuvant ThErapy in Renal Cell Carcinoma (RCC)RecruitingNCT06005818Phase 2
- Neoadjuvant Pembrolizumab and Axitinib in Renal Cell Carcinoma With Inferior Vena Cava Tumor ThrombusRecruitingNCT05969496Phase 2
- OPTI - DOSE: Optimal Dosing of Oral Anticancer Drugs in Older AdultsNot yet recruitingNCT05949424Phase 4
- Primary Metastatic Renal Cell Carcinoma Treated With Immunecheckpoint Inhibitors and Cytoreductive NephrectomyNot yet recruitingNCT05941169Not applicable
- Sequential Treatment of Cabozantinib for Advanced Renal Cell Carcinoma (RCC)RecruitingNCT05931393Phase 2
- Renal Cancer Monitoring Based on ctDNA Methylomics: A Prospective Cohort Study (MEMORY Study)RecruitingNCT05917106
- 68Ga-NY104 PET/CT Imaging in Renal Cell CarcinomaRecruitingNCT05902377Phase 2
- Engineering Immune Organoids to Study Pediatric CancerRecruitingNCT05890781Not applicable
- 68Ga-NY104 PET/CT for the Detection of Clear Cell Renal Cell Carcinoma in Presurgical Patients With Renal MassesRecruitingNCT05879510Phase 2
- 68Ga-NY104 PET/CT in Patients With Metastatic Clear Cell Renal Cell CarcinomaRecruitingNCT05879471Phase 2
- Combination of 177Lu-TLX250 and Peposertib in Patients With Carbonic Anhydrase IX -Expressing Solid TumorsRecruitingNCT05868174Phase 1
- A Study of Oncobax®-AK in Patients With Advanced Solid TumorsRecruitingNCT05865730Phase 2
- Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid TumorsRecruitingNCT05856981Phase 1
- A Study of BPI-452080 in Subjects With Solid TumorsNot yet recruitingNCT05843305Phase 1
- A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft TissueRecruitingNCT05837767Not applicable
- Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell CarcinomaRecruitingNCT05830058Phase 2
- A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)RecruitingNCT05824975Phase 1/2
- Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC PatientsRecruitingNCT05817903Phase 2
- Comparison of Postoperative Analgesic Efficacy of the Erector Spina Plane Block and Quadratus Lumborum Block in Open Nephrectomy: a Prospective Randomized Clinical StudyRecruitingNCT05810571Not applicable
- Evaluation of the Safety and Efficacy of Sodium Pentaborate Pentahydrate in Patients With Advanced Renal Cell CarcinomaNot yet recruitingNCT05798455Phase 1/2
- Measuring Oncological Value of Exercise and StatinRecruitingNCT05796973Phase 3
- Safety and Efficacy of Sutureless Zero Ischemia Laparoscopic Tumor Enucleation for T1 Stage Renal CarcinomaRecruitingNCT05790122
- Biomarkers of Renal CancerRecruitingNCT05785052
- DETERMINE Trial Treatment Arm 01: Alectinib in Adult, Paediatric and Teenage/Young Adult Patients With ALK Positive CancersRecruitingNCT05770037Phase 2/3
- Postoperative Adjuvant Therapy for Non-clear Renal Cell Carcinoma With High-risk Recurrence FactorsRecruitingNCT05768464Phase 2
- First-in-human Phase I Study to Evaluate Safety, Tolerability and Antineoplastic Activity of OATD-02 in Patients With Selected Advanced and/or Metastatic Solid TumoursRecruitingNCT05759923Phase 1
- The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN TrialRecruitingNCT05753839Not applicable
- Neoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell CarcinomaRecruitingNCT05738694Phase 3
- Neoadjuvant Pembrolizumab and Lenvatinib for Renal Cell CarcinomaRecruitingNCT05733715Early Phase 1
- Renal Mass Biopsy, PEER, and 99mTc-sestamibi SPECT/CT for Patients With Clinically Localized Renal TumorsRecruitingNCT05728957
- Transplantation of Reconstructed Renal Allografts Following Ex-Vivo Partial NephrectomyNot yet recruitingNCT05725421Not applicable
- A Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid TumorsRecruitingNCT05706129Phase 1/2
- A Companion Diagnostic Study to Develop Circulating Exosomes as Predictive Biomarkers for the Response to Immunotherapy in Renal Cell CarcinomaRecruitingNCT05705583
- Drug Screening Using Novel IMD in Renal Cell CarcinomaRecruitingNCT05700461Phase 1
- Clinical Study to Evaluate Safety and Dosing of CA9hu-1 in Patients With Advanced Solid TumoursNot yet recruitingNCT05698238Phase 1
- Palbociclib and Sasanlimab for the Treatment of Advanced Clear Cell Renal Cell Carcinoma (ccRCC) or Papillary Renal Cell Carcinoma (pRCC)RecruitingNCT05665361Phase 1/2
- Contrast-Enhanced Ultrasound Imaging for Diagnosing Recurrent Renal Cell Carcinoma (RCC) Post AblationRecruitingNCT05641935Phase 2
- Quantifying Systemic Immunosuppression to Personalize Cancer TherapyRecruitingNCT05621837
- Predicting Model Based on Evidence-based Pathological Diagnose Criteria for RCC Tumor Thrombus With IVC Wall InvasionRecruitingNCT05589207
- Pembrolizumab Plus Radiotherapy for Advanced Renal CancerRecruitingNCT05567588Phase 2
- A Prospective Study to Evaluate the Implementation of Shared Decision Making Strategy for Renal Cell Cancer (RCC)RecruitingNCT05548621
- A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid TumorsRecruitingNCT05536141Phase 1
- Frequency, Clinical Phenotype and Genetic Analysis of Heritable Kidney Cancer SyndromesRecruitingNCT05534854
- Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary CancersRecruitingNCT05519878Not applicable
- A Clinical Study of CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Solid TumorsRecruitingNCT05518253Phase 1
- A Clinical Research About CD70-positive Advanced/Metastatic Solid Tumors Treated by CD70-targeted CAR-TRecruitingNCT05468190Phase 1
- Integrative Molecular Characterization Of MiT Family Translocation Renal Cell Carcinomas (IMCOR)Not yet recruitingNCT05456074